← FDA Drug Approvals (Drugs@FDA)

PITAVASTATIN CALCIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2024-04-30

Drug application

FDA Application #
ANDA205977
Application type
Abbreviated New Drug Application (Generic)
Brand name
PITAVASTATIN CALCIUM
Generic name
PITAVASTATIN CALCIUM
Active ingredients
PITAVASTATIN CALCIUM
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
HETERO LABS LTD V
Manufacturer
NorthStar RxLLC
First approval
2024-04-30

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown